Fátima Serrano

Fátima Serrano

Auto-generated profile, based on publicly available information

Fátima Serrano

Department of Obstetrics , 90463 Central Lisbon University Hospitals , Lisbon , Portugal

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2006 in Psychology and Psychotherapy: Theory, Research and Practice
Verified
Journal Article
Closed access
PDF file
FSFátima Serrano
Fátima Serrano
LLLuisa Lima
Luisa Lima

28 February 2018 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
MTMarta Tonello
Marta Tonello
AHAriela Hoxha
Ariela Hoxha
Savino SciasciaSavino Sciascia
Savino Sciascia
MCMaria J. Cuadrado
Maria J. Cuadrado
JLJosé O. Latino
José O. Latino
ARAmelia Ruffatti
Amelia Ruffatti
The effect of additional treatments combined with conventional therapy on pregnancy outcomes was examined in high-risk primary antiphospholipid syndrome (PAPS) patients to identify the most effective treatment strategy. The study's inclusion criteria were (1) positivity to lupus anticoagulant alone or associated with anticardiolipin and/or anti-β2 glycoprotein I antibodies; (2) a history of severe maternal–foetal complications (Group I) or a history of one or more pregnancies refractory to conventional therapy leading to unexplained foetal deaths not associated with severe maternal–foetal complications (Group II). Two different additional treatments were considered: oral—low-dose steroids (10–20 mg prednisone daily) and/or 200 to 400 mg daily doses of hydroxychloroquine and parenteral—intravenous immunoglobulins at 2 g/kg per month and/or plasma exchange. The study's primary outcomes were live birth rates and pregnancy complications. A total of 194 pregnant PAPS patients attending 20 tertiary centres were retrospectively enrolled. Hydroxychloroquine was found to be linked to a significantly higher live birth rate with respect to the other oral treatments in the Group II patients. The high (400 mg) versus low (200 mg) doses of hydroxychloroquine (p = 0.036) and its administration before versus during pregnancy (p = 0.021) were associated with a significantly higher live birth rate. Hydroxychloroquine therapy appeared particularly efficacious in the PAPS patients without previous thrombosis. Parenteral treatments were associated with a significantly higher live birth rate with respect to the oral ones (p = 0.037), particularly in the Group I patients. In conclusion, some additional treatments were found to be safe and efficacious in high-risk PAPS pregnant women.

27 June 2009 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
PAPaula Ambrósio
Paula Ambrósio
RLRita Lermann
Rita Lermann
ACAlexandra Cordeiro
Alexandra Cordeiro
ABAugusta Borges
Augusta Borges
INIsabel Nogueira
Isabel Nogueira
FSFátima Serrano
Fátima Serrano

23 August 2019 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
CRCatarina R. Palma dos Reis
Catarina R. Palma dos Reis
GCGonçalo Cardoso
Gonçalo Cardoso
CCCarolina Carvalho
Carolina Carvalho
INIsabel Nogueira
Isabel Nogueira
ABAugusta Borges
Augusta Borges
FSFátima Serrano
Fátima Serrano

1 September 2016 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
ABArnaldo Batista
Arnaldo Batista
SNShirin Najdi
Shirin Najdi
DGDaniela M. Godinho
Daniela M. Godinho
CMCatarina Martins
Catarina Martins
FSFátima C. Serrano
Fátima C. Serrano
RRRaul T. Rato
Raul T. Rato

9 October 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
FCFilipa Cardoso
Filipa Cardoso
ABArnaldo Batista
Arnaldo Batista
HMHelena Mouriño
Helena Mouriño
SRSara Russo
Sara Russo
CRCatarina R. Palma dos Reis
Catarina R. Palma dos Reis
Manuel OrtigueiraManuel Ortigueira
Manuel Ortigueira
Electrohysterography (EHG) is a promising technique for pregnancy monitoring and preterm risk evaluation. It allows for uterine contraction monitoring as early as the 20th gestational week, and it is a non-invasive technique based on recording the electric signal of the uterine muscle activity from electrodes located in the abdominal surface. In this work, EHG-based contraction detection methodologies are applied using signal envelope features. Automatic contraction detection is an important step for the development of unsupervised pregnancy monitoring systems based on EHG. The exploratory methodologies include wavelet energy, Teager energy, root mean square (RMS), squared RMS, and Hilbert envelope. In this work, two main features were evaluated: contraction detection and its related delineation accuracy. The squared RMS produced the best contraction (97.15 ± 4.66%) and delineation (89.43 ± 8.10%) accuracy and the lowest false positive rate (0.63%). Despite the wavelet energy method having a contraction accuracy (92.28%) below the first-rated method, its standard deviation was the second best (6.66%). The average false positive rate ranged between 0.63% and 4.74%—a remarkably low value.